Most Read News

Revenue increased 11% YoY to ₹265.30 crore from ₹240 crore in Q4 FY24, suggesting healthy sales traction.

The Board of Directors have recommended a final dividend of ₹35 per equity share, i.e., 350% for the financial year FY25

Revenue from operations was down by 20.3% y-o-y to ₹1,360.9 crore in Q4 FY25 from ₹1,708.2 crore in Q4 FY24

The company also said this issue relates to the entire industry where the GST department has sent notices to various other gaming companies prior to this.

The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24

The business also announced aggressive plans to diversify into competitive tyre segments via hefty capital expenditure.

An EBITDA of ₹498 crore at Q4 FY25 shrank by 6.4% over ₹532.2 crore in the corresponding quarter last year.

Revenue from operations in the quarter was at ₹534 crore, a 13% increase from ₹471 crore in Q4 FY24

The two stocks that have touched their 52-week highs are ICICI bank and HDFC Life

The company has a strong foothold in the Indian pharma market as well as in the international market where it sells its products in more than 55 countries